Lincoject
Active substance
ATC code
Species
Pigs
Dogs
Cats
Indications
In dogs and cats, Lincoject is recommended for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms, particularly streptococci and staphylococci and certain Gram-negative anaerobic bacteria (e.g. Bacteroides, Fusobacterium species).
Lincoject is recommended for treatment of the following conditions in dogs and cats: Tonsillitis, laryngitis and other respiratory tract infections; abscesses, infected wounds and purulent dermatitis; septicaemia.
In pigs, Lincoject is indicated for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms (e.g. staphylococci, streptococci), certain Gram-negative anaerobic organisms (e.g. Serpulina (Treponema) hyodysenteriae, Bacteroids, Fusobacterium and Mycoplasma species).
Lincoject is recommended for treatment of the following conditions in pigs: Swine dysentry, enzootic or mycoplasmal pneumonia, septic arthritis, foot abscesses.
Dose to be administered and administration route
Lincoject is indicated for intravenous and intramuscular administration to dogs and cats and intramuscular administration to pigs.
CATS AND DOGS:
Intramuscularly: 22 mg/kg of bodyweight once daily or 11 mg/kg every 12 hours.
Intravenously: 11 to 22 mg/kg one or two times per day by slow intravenous injection.
PIGS:
Intramuscularly: 4.5 to 11 mg/kg of bodyweight once daily.
To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.
Adverse reactions
The intramuscular administration of Lincoject to pigs at higher levels than recommended may result in diarrhoea and loose stools.
References
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | |
| EAN | 5023534003021 |
Similar products
Showing 1 of 1 results
